Arcadia Biosciences appoints Thomas Schaefer as CFO, succeeding Pamela Haley

Arcadia Biosciences, Inc.

Pamela Haley resigns as CFO effective January 3, 2023; will stay in advisory role.
Thomas J. Schaefer, current VP of Finance and IR, promoted to CFO effective same date.
Schaefer has 20+ years finance experience, previously at Flavor Producers and Edward Jones, holds CFA.
Schaefer led commercial launch of GoodWheat and development of long-term strategy Project Greenfield.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Pamela Haley

chief financial officer

RKDA · Arcadia Biosciences, Inc.

Successor: Thomas J. Schaefer
Filed: November 30, 2022, 6:59 PM ET

On November 28, 2022, Pamela Haley provided notice to Arcadia Biosciences, Inc. (“Arcadia”) of her resignation as Arcadia’s chief financial officer, effective as of January 3, 2022.

Appointed

Thomas J. Schaefer

chief financial officer

RKDA · Arcadia Biosciences, Inc.

Filed: November 30, 2022, 6:59 PM ET

On November 30, 2022 and effective January 3, 2022, Arcadia’s board of directors appointed Thomas J. Schaefer as Arcadia’s new chief financial officer to succeed Ms. Haley.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Pamela Haley resigned as chief financial officer at Arcadia Biosciences, Inc..

Action: resigned
Role: chief financial officer

Exact text from the filing

On November 28, 2022, Pamela Haley provided notice to Arcadia Biosciences, Inc. (“Arcadia”) of her resignation as Arcadia’s chief financial officer, effective as of January 3, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas J. Schaefer was appointed as chief financial officer at Arcadia Biosciences, Inc..

Action: appointed
Role: chief financial officer

Exact text from the filing

On November 30, 2022 and effective January 3, 2022, Arcadia’s board of directors appointed Thomas J. Schaefer as Arcadia’s new chief financial officer to succeed Ms. Haley.

View on SEC.gov

Arcadia Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-025876

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.